This project, which will commence on 1 March and is expected to last for 4 years, has a budget of €13 M, of which €10.5 M are provided by the EU.
Its main objective is to develop new nanotechnology-based systems for the screening and subsequent effective treatment of the most malignant type of cancer known—80% of patients with pancreatic cancer die
23/03/2011
Two Basque centres, namely CIC biomaGUNE and CIDETEC-IK4, participate in an ambitious European project (SaveMe) led by the University of Tel Aviv involving a total of 20 scientific/technological bodies from 9 countries